Keywords: ligand, alrt, retinoids, progress, joint-venture, company, allergan

Ligand And ALRT; Retinoids Progress

Article | 15 January 1996

Joint-venture company Allergan Ligand Retinoid Therapeutics has started a Phase III clinical trial of ALRT1057 Topical (9-cis-retinoic acid) for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in